Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

This study has been terminated.
Sponsor:
Collaborators:
Pharmacia and Upjohn
Triangle Pharmaceuticals
Information provided by:
Bristol-Myers Squibb
ClinicalTrials.gov Identifier:
NCT00002420
First received: November 2, 1999
Last updated: August 13, 2008
Last verified: August 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: No date given
  Primary Completion Date: No date given